Withania somnifera — known in Ayurvedic medicine as ashwagandha — has been used for over 3,000 years as an adaptogen: a class of plants that help the body regulate its response to biological stress. For most of that history, its mechanisms were understood empirically, through observed effects across generations.
Over the last two decades, clinical research has begun to explain the underlying pharmacology. Ashwagandha's primary active compounds, withanolides, appear to modulate the hypothalamic-pituitary-adrenal (HPA) axis — the system that governs cortisol production and release.
The most rigorously studied form, a standardised root extract known as KSM-66®, has now been through multiple randomised, double-blind, placebo-controlled trials — the gold standard of clinical evidence. The results have been consistent.